NTC grants further license and distribution rights to Santen for its fixed combination dexamethasone with levofloxacin in South East Asia

  • May 22, 2019

Milan, Italy, May 22, 2019 – NTC Srl, R&D driven pharmaceutical company with headquarters in Italy, and Santen Pharmaceutical Co. Ltd, a global leader in ophthalmology, announce today the extension of their original agreement for Europe signed in December 2017.

NTC closes a deal with Bruno Farmaceutici for the development of a new solution to treat external and medium otitis with tympanostomy in children.

  • Feb 26, 2019

Milan, February 26th 2019 – NTC Srl, an Italian pharmaceutical company with significant expertise in research and development in ophthalmology, announces today a commercial partnership with Bruno Farmaceutici S.p.A.

NTC Pharma España moves the first steps in the world of Ophthalmology in Spain

  • Feb 03, 2019

During FacoElche Congress (31st January – 2nd February 2019), NTC Ophthalmics Ibérica organized its first Symposium focused on the rational use of topical antibiotics in ophthalmology.

Beyond CPhI: NTC is running talks and negotiations with the aim to reinforce and expand its reach internationally

  • Nov 27, 2018

One month passed since last CPhI in Madrid. There, NTC team met more than 200 potential customers and suppliers coming from 50 countries all over the world.